Literature DB >> 15492509

Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS.

Magdalene K Sgagias1, Kay-Uwe Wagner, Brad Hamik, Scott Stoeger, Rebecca Spieker, L Julie Huber, Lewis A Chodosh, Kenneth H Cowan.   

Abstract

In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(fl/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1(-/-) MMECs were generated by deletion of exon 11 following transduction of Brca1(fl/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride (CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECS is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays out in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492509     DOI: 10.4161/cc.3.11.1211

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  20 in total

Review 1.  Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.

Authors:  Elena S Ratner; Alan C Sartorelli; Z Ping Lin
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

2.  N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.

Authors:  Muhammad Zahid; Muhammad Saeed; Mohammed F Ali; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2010-05-31       Impact factor: 7.376

3.  Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.

Authors:  Rebecca S Muraoka-Cook; Laura S Caskey; Melissa A Sandahl; Debra M Hunter; Carty Husted; Karen E Strunk; Carolyn I Sartor; William A Rearick; Wesley McCall; Magdalene K Sgagias; Kenneth H Cowan; H Shelton Earp
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.

Authors:  Samuele Lodovichi; Martina Vitello; Tiziana Cervelli; Alvaro Galli
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

5.  DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer.

Authors:  Brian M Alexander; Kam Sprott; D Allan Farrow; XiaoZhe Wang; Alan D D'Andrea; Stuart J Schnitt; Laura C Collins; David T Weaver; Judy E Garber
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

6.  The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.

Authors:  Mireia Margeli; Beatriz Cirauqui; Eva Castella; Gustavo Tapia; Carlota Costa; Ana Gimenez-Capitan; Agusti Barnadas; Maria Sanchez Ronco; Susana Benlloch; Miquel Taron; Rafael Rosell
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

7.  A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.

Authors:  Aleata A Triplett; Cristina Montagna; Kay-Uwe Wagner
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

8.  Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.

Authors:  Elizabeth Alli; Vandana B Sharma; Preethi Sunderesakumar; James M Ford
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Reduction of estrogen-induced transformation of mouse mammary epithelial cells by N-acetylcysteine.

Authors:  Divya Venugopal; Muhammad Zahid; Paula C Mailander; Jane L Meza; Eleanor G Rogan; Ercole L Cavalieri; Dhrubajyoti Chakravarti
Journal:  J Steroid Biochem Mol Biol       Date:  2007-12-07       Impact factor: 4.292

10.  Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.

Authors:  Katherine V Clark-Knowles; Mary K Senterman; Olga Collins; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.